High Prevalence of Chronic Hepatitis B Infection among Injection Drug Users in Iran: The Need to Increase Vaccination of Adults at Risk

High Prevalence of Chronic Hepatitis B Infection among Injection Drug Users in Iran: The Need to Increase Vaccination of Adults at Risk

Show other versions (1)

We measured the prevalence of HBV surface antigen (HBsAg) among male injection drug users (IDUs) in Detention, Tehran, Iran. A cross-sectional survey included 499 male IDUs arrested by police during a predetermined police sweep in Tehran (February, 2006). A questionnaire was filled out for each indi...

Full description

Bibliographic Details
Main Authors: Seyed Ahmad SeyedAlinaghi, Parastoo Kheirandish, Nazli Karami, Sepehr Salem, Hadi Shirzad, Mohammad Reza Jahani, Mohammad Reza SeyedAhmadian, Pegah Valiollahi, Mostafa Hosseini, Minoo Mohraz, Willi McFarland
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-02-01
Series:Acta Medica Iranica
Subjects:
Prevalence
hepatitis B surface antigen
drug users
vaccination
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/3648
Description
Summary:We measured the prevalence of HBV surface antigen (HBsAg) among male injection drug users (IDUs) in Detention, Tehran, Iran. A cross-sectional survey included 499 male IDUs arrested by police during a predetermined police sweep in Tehran (February, 2006). A questionnaire was filled out for each individual. Blood specimens were collected for HBsAg testing. Prevalence of HBsAg was 5.8% (95% CI 3.6-7.9). The majority of chronic HBV infections, 69.2%, were among adults age 25 to 34 years. The high prevalence of HBsAg highlights the need for special efforts to increase vaccination among adult populations at risk for HBV infection in order to reducing continuing transmission and stave off future high burden of disease.
ISSN:0044-6025
1735-9694

Similar Items